Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury

被引:0
|
作者
Rosanna Di Paola
Salvatore Cuzzocrea
机构
[1] University of Messina,Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine
[2] Torre Biologica-Policlinico Universitario,undefined
[3] IRCCS Centro Neurolesi Bonino-Pulejo,undefined
关键词
Peroxisome proliferator-activated receptors; Ischemia; Reperfusion tissue injury;
D O I
暂无
中图分类号
学科分类号
摘要
Peroxisome proliferator-activated receptors (PPARs) belong to a subfamily of transcription nuclear factors. Three isoforms of PPARs have been identified: α, β/δ and γ, encoded by different genes and distributed in various tissues. They play important roles in metabolic processes like regulation of glucose and lipid redistribution. They also have anti-atherogenic, anti-inflammatory as well as antihypertensive functions. There is good evidence that ligands of PPARs reduce tissue injury associated with ischemia and reperfusion. The potential utility of PPAR ligands in ischemia and reperfusion will be discussed in this review.
引用
收藏
页码:157 / 175
页数:18
相关论文
共 50 条
  • [21] Sildenafil obviates ischemia-reperfusion injury-induced acute kidney injury through peroxisome proliferator-activated receptor γ agonism in rats
    Mohey, Vinita
    Singh, Manjinder
    Puri, Nikkita
    Kaur, Tajpreet
    Pathak, Devendra
    Singh, Amrit Pal
    JOURNAL OF SURGICAL RESEARCH, 2016, 201 (01) : 69 - 75
  • [22] Activation of peroxisome proliferator-activated receptor-α protects the heart from ischemia/reperfusion injury
    Yue, TL
    Bao, W
    Jucker, BM
    Gu, JL
    Romanic, AM
    Brown, PJ
    Cui, JQ
    Thudium, DT
    Boyce, R
    Burns-Kurtis, CL
    Mirabile, RC
    Aravindhan, K
    Ohlstein, EH
    CIRCULATION, 2003, 108 (19) : 2393 - 2399
  • [23] Peroxisome proliferator-activated receptor-γ protects against hepatic ischemia/reperfusion injury in mice
    Kuboki, Satoshi
    Shin, Thomas
    Huber, Nadine
    Eismann, Thorsten
    Galloway, Elizabeth
    Schuster, Rebecca
    Blanchard, John
    Zingarelli, Basifia
    Lentsch, Alex B.
    HEPATOLOGY, 2008, 47 (01) : 215 - 224
  • [24] Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-γ ligand, on lung ischemia-reperfusion injury in rats
    Ito, K
    Shimada, J
    Kato, D
    Toda, S
    Takagi, T
    Naito, Y
    Yoshikawa, T
    Kitamura, N
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2004, 25 (04) : 530 - 536
  • [25] Protective effects of peroxisome proliferator-activated receptor γ ligand on apoptosis and hepatocyte growth factor induction in renal ischemia-reperfusion injury
    Doi, Shigehiro
    Masaki, Takao
    Arakawa, Tetsuji
    Takahashi, Shunsuke
    Kawai, Toru
    Nakashima, Ayumu
    Naito, Takayuki
    Kohno, Nobuoki
    Yorioka, Noriaki
    TRANSPLANTATION, 2007, 84 (02) : 207 - 213
  • [26] Proliferating peroxisome proliferator-activated receptors
    不详
    DIABETES OBESITY & METABOLISM, 2000, 2 (05): : 332 - 333
  • [27] THE DIOXIN AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS - NUCLEAR RECEPTORS IN SEARCH OF ENDOGENOUS LIGANDS
    POELLINGER, L
    GOTTLICHER, M
    GUSTAFSSON, JA
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (06) : 241 - 245
  • [28] Peroxisome proliferator-activated receptors and inflammation
    Moraes, Leonardo A.
    Piqueras, Laura
    Bishop-Bailey, David
    PHARMACOLOGY & THERAPEUTICS, 2006, 110 (03) : 371 - 385
  • [29] Peroxisome proliferator-activated receptors and their functions
    Jiao, HL
    Ye, P
    Zhao, BL
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2001, 28 (04) : 478 - 481
  • [30] Peroxisome proliferator-activated receptors for hypertension
    Usuda, Daisuke
    Kanda, Tsugiyasu
    WORLD JOURNAL OF CARDIOLOGY, 2014, 6 (08): : 744 - 754